Although the P1+pre-Rad regimen improved the tumor immune microenvironment, unIR tumor growth were similarly suppressed by both P1+pre-Rad and P1+conc-Rad regimens, suggesting that addition of radiation to P1 therapy is crucial for achieving systemic tumor response regardless of sequence of radiation in P1 therapy. Here, RRAD is linked to neoplasm.